Gnomestar Craft Inc. (VDQSF) Stock Analysis

Why this analysis is different

• A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Gnomestar Craft Inc. (VDQSF) Healthcare & Pipeline Overview

Gnomestar Craft Inc. cultivates and supplies cannabis for Canada's medical and adult-use markets from its Delta, CA base. Established in 2011, this micro-cap entity, formerly Vodis Pharmaceuticals, navigates a highly regulated sector with significant operational challenges, reflected in its OTC Other listing and current financial metrics.

What Is the Investment Thesis for VDQSF?

Gnomestar Craft Inc. (VDQSF) operates within the dynamic Canadian cannabis market, focusing on both medical and adult-use cultivation and supply. The investment thesis centers on the potential for market share capture within this growing sector, despite the company's current financial challenges. With a market capitalization of $5.25M, VDQSF is a micro-cap entity characterized by significant negative profitability, evidenced by a profit margin of -328.5% and a gross margin of -101.5%. These metrics highlight operational inefficiencies or early-stage investment in growth. Key growth catalysts include the continued expansion of the Canadian adult-use cannabis market and the stable demand within the medical cannabis segment. As regulatory frameworks mature and consumer acceptance increases, companies like Gnomestar Craft Inc. could benefit from increased sales volumes and potential economies of scale. However, the company's high beta of 3.72 indicates significant price volatility, reflecting its speculative nature and sensitivity to market movements. The OTC Other listing further introduces risks related to liquidity and information availability, demanding thorough due diligence. Future value drivers would involve demonstrating a clear path to profitability, improving operational efficiency, and successfully differentiating its product offerings in a competitive landscape.

Based on FMP financials and quantitative analysis

VDQSF Key Highlights

Market capitalization of $5.25M, indicating a micro-cap company operating in a specialized sector.

• Profit margin of -328.5%, reflecting significant unprofitability and substantial operational losses.
• Gross margin of -101.5%, suggesting that the cost of goods sold currently exceeds revenue, indicating severe operational challenges.
• Beta of 3.72, signaling high price volatility and sensitivity to broader market fluctuations.
• Operates in both the medical and adult-use cannabis markets in Canada, providing exposure to a growing, yet highly regulated, industry.

Who Are VDQSF's Competitors?

VDQSF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are VDQSF's Key Strengths?

Established presence in the Canadian cannabis market since 2011 (as Vodis Pharmaceuticals Inc.), indicating operational longevity.

• Licensed to operate in both medical and adult-use cannabis segments, diversifying market access.
• Operational base in Delta, Canada, providing a strategic location for cultivation and distribution within British Columbia.

What Are VDQSF's Weaknesses?

Significant negative profitability, with a profit margin of -328.5% and gross margin of -101.5%.

• Micro-cap status ($5.25M market cap) implies limited access to capital and resources for expansion.
• High stock volatility indicated by a Beta of 3.72, suggesting increased investment risk.
• OTC Other listing presents challenges related to liquidity, transparency, and information availability.

What Could Drive VDQSF Stock Higher?

VDQSF catalyst: Potential for new product launches or expanded product lines in the Canadian adult-use or medical cannabis markets.

• Any positive regulatory developments or liberalization within the Canadian cannabis industry that could expand market opportunities.
• Efforts to improve operational efficiency and reduce the significant negative gross and profit margins, leading to improved financial performance.
• Strategic partnerships or distribution agreements that could expand market reach and enhance brand visibility across Canada.

What Are the Key Risks for VDQSF?

Financial-distress signal — its Altman Z-Score of -26.20 sits in the distress zone (elevated bankruptcy risk).

• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Persistent unprofitability, as evidenced by a -328.5% profit margin and -101.5% gross margin, indicating fundamental operational challenges.
• Intense competition within the fragmented Canadian cannabis market from larger, better-funded players with established market share.
• Regulatory changes or increased taxation that could negatively impact the cannabis industry's growth or Gnomestar Craft Inc.'s operations.
• Challenges in securing additional capital to fund operations and growth initiatives due to its micro-cap and OTC status and current financial performance.
• High stock price volatility (Beta 3.72) and low liquidity associated with its OTC Other listing, increasing investment risk.

What Are the Growth Opportunities for VDQSF?

• Expansion in the Adult-Use Cannabis Market: The Canadian adult-use cannabis market continues to expand as consumer preferences evolve and illicit market conversion progresses. Gnomestar Craft Inc. has an opportunity to increase its market share by enhancing brand recognition and expanding distribution channels for its recreational products. With the market projected to grow steadily, capturing even a small percentage of this expansion could significantly impact revenue. This growth driver is ongoing, with market maturation expected over the next 3-5 years, driven by new product formats and increased consumer accessibility. The total Canadian cannabis market was valued at approximately CAD 4 billion in 2022 and is projected to reach CAD 6.7 billion by 2027.
• Growth in the Medical Cannabis Sector: The medical cannabis market in Canada provides a stable and often less price-sensitive demand segment. Gnomestar Craft Inc. can capitalize on this by strengthening its relationships with medical practitioners and patient advocacy groups, ensuring its products meet the specific quality and efficacy standards required for therapeutic use. This segment benefits from ongoing research into cannabis applications and increasing patient access. This is an ongoing opportunity, with consistent demand driven by patient needs and evolving medical understanding, providing a foundational revenue stream for the company. The medical cannabis market in Canada is a significant component of the overall market, estimated at over CAD 500 million annually.
• Product Diversification and Innovation: The cannabis market is increasingly moving beyond traditional dried flower into a variety of value-added products such as edibles, concentrates, vapes, and topicals. Gnomestar Craft Inc. has an opportunity to innovate and diversify its product portfolio to meet these evolving consumer demands. Introducing new, high-quality product formats could attract new customer segments and increase per-customer spending. This opportunity is ongoing, with new product development cycles typically ranging from 12-24 months, allowing the company to adapt to market trends and capture premium segments. Successfully launching differentiated products could significantly enhance margins.
• Optimizing Cultivation and Supply Chain Efficiency: Improving operational efficiency in cultivation and supply chain management represents a significant growth opportunity, especially given the company's current negative gross margins. Implementing advanced cultivation techniques, optimizing resource allocation, and streamlining logistics can reduce costs per gram and improve overall profitability. Such efficiencies would allow Gnomestar Craft Inc. to become more competitive on pricing or improve its bottom line. This is an ongoing internal opportunity, with continuous improvements potentially yielding benefits over the next 1-3 years, directly impacting the company's financial health and sustainability.
• Strategic Partnerships and Distribution Expansion: Forming strategic partnerships with established distributors, retailers, or other licensed producers could significantly expand Gnomestar Craft Inc.'s market reach without substantial capital expenditure. Collaborations could open new provincial markets or enhance penetration in existing ones, particularly for adult-use products. Leveraging partners' existing infrastructure can accelerate growth and brand exposure. This is an ongoing opportunity, with potential partnerships developing over the next 1-2 years, allowing the company to scale its operations and brand presence more effectively across the fragmented Canadian market.

What Threats Does VDQSF Face?

• Intense competition from larger, well-capitalized licensed producers with greater market share and resources.
• Evolving and potentially restrictive regulatory changes in the Canadian cannabis industry that could impact operations or sales.
• Challenges in securing additional financing due to micro-cap status and persistent negative profitability.
• Market sentiment shifts and potential for further price volatility, exacerbated by its OTC listing.

What Are VDQSF's Competitive Advantages?

• Established operational history since 2011 (as Vodis Pharmaceuticals Inc.), providing experience in a relatively nascent and evolving industry.
• Regulatory compliance and holding necessary licenses within the stringent Canadian cannabis framework, which acts as a significant barrier to entry for new players.
• Participation in both the medical and adult-use cannabis markets, diversifying its revenue streams and market exposure.

What Does VDQSF Do?

Gnomestar Craft Inc., trading under the ticker VDQSF, is a Canadian-based company primarily engaged in the cultivation and supply of cannabis products for both medical and adult-use markets. Established in 2011, the company initially operated as Vodis Pharmaceuticals Inc. before undergoing a rebranding and officially adopting its current name, Gnomestar Craft Inc., in December 2020. This strategic evolution reflects its continued focus on the burgeoning Canadian cannabis industry. Headquartered in Delta, British Columbia, Gnomestar Craft Inc. leverages its operational base to serve a diverse customer base across the country. The company's business model centers on the production of cannabis, encompassing the entire supply chain from cultivation to distribution. This involves adhering to stringent Canadian regulatory frameworks governing cannabis production, which include licensing, quality control, and distribution protocols. By participating in both the medical and recreational segments, Gnomestar Craft Inc. aims to diversify its revenue streams and capitalize on the distinct demand drivers within each market. The medical cannabis segment typically serves patients with specific health conditions, requiring products that meet pharmaceutical-grade standards, while the adult-use market caters to a broader consumer base seeking recreational cannabis products. Gnomestar Craft Inc.'s operational footprint in Delta, Canada, positions it within a region known for its agricultural capabilities and proximity to key distribution networks. The company's long-standing presence, dating back to 2011, suggests an established understanding of the market dynamics and regulatory landscape, which are critical for success in the highly regulated cannabis sector. As a manufacturer and distributor, Gnomestar Craft Inc. is part of a competitive industry, where differentiation through product quality, brand recognition, and efficient supply chain management are paramount. Its transition and continued operation underscore its commitment to adapting and growing within the evolving Canadian cannabis market, aiming to carve out a niche for its cultivated products.

What Products and Services Does VDQSF Offer?

• Cultivates cannabis plants for both medical and adult-use markets in Canada.
• Supplies a range of cannabis products to consumers within the Canadian market.
• Operates within the highly regulated Canadian cannabis industry, adhering to federal and provincial guidelines.
• Focuses on the production and distribution of cannabis from its operational base in Delta, British Columbia.
• Manages the entire supply chain process, from initial plant growth and cultivation to final market delivery.
• Aims to serve both licensed patients requiring medical cannabis and recreational adult-use consumers.

How Does VDQSF Make Money?

• Generates revenue through the direct sale of cultivated medical cannabis products to authorized patients or distributors.
• Earns income from the sale of adult-use recreational cannabis products through regulated channels in Canada.
• Operates as a licensed producer and distributor, leveraging its compliance with Canadian regulatory frameworks to access the market.

What Industry Does VDQSF Operate In?

Gnomestar Craft Inc. operates within the Canadian Drug Manufacturers - Specialty & Generic industry, specifically focusing on the cultivation and supply of cannabis. The Canadian cannabis market, legalized for adult-use in 2018, continues to evolve, characterized by increasing consumer adoption and ongoing regulatory adjustments. This industry is highly competitive, featuring numerous licensed producers ranging from large, publicly traded corporations to smaller, craft-focused cultivators. Market trends include a shift towards value-added products like edibles, beverages, and concentrates, alongside a sustained demand for traditional dried flower. Gnomestar Craft Inc., with its origins dating back to 2011 as Vodis Pharmaceuticals Inc., positions itself as an established player in this dynamic landscape, concentrating its operations in Delta, Canada. As an OTC-listed micro-cap, the company competes for market share by focusing on its cultivation and supply capabilities for both medical and adult-use segments, aiming to differentiate itself amidst larger, more capitalized competitors. The overall industry growth is driven by expanding legal access and changing consumer preferences, though profitability remains a challenge for many participants.

Who Are VDQSF's Key Customers?

• Licensed medical cannabis patients in Canada who require cannabis for therapeutic purposes.
• Adult-use recreational cannabis consumers across various Canadian provinces.
• Potentially provincial cannabis boards or wholesale buyers for distribution to retail outlets.

Company Profile

Gnomestar Craft Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Delta, CA. The company is led by CEO Mark Lotz BBA, CA,. VDQSF has traded publicly since 2015.

Gnomestar Craft Inc. (VDQSF) Valuation Context

Valued at $5.25M, VDQSF is classified as a micro-cap stock. Relative to its peer group, VDQSF's quantitative score of 44/100 is below the peer average of 62/100.

Return on equity for Gnomestar Craft Inc. stands at 57.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -71.8%, showing how much profit it generates from its asset base. Its free cash flow yield is -3.7%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.14 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -79.7%, the inverse of the P/E and a quick read on earnings relative to price.

Gnomestar Craft Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -26.20 places it in the distress zone, a signal of elevated financial risk.

VDQSF Financials

VDQSF Latest News

No recent news available for VDQSF.

VDQSF Analyst Consensus

VDQSF MoonshotScore

Common Questions About VDQSF (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources